MCNALLY ROBERT T 4

What Happened
Robert T. McNally, a director of GeoVax Labs, was granted 6,000 shares in a derivative award on 2026-06-17. The filing reports an acquisition price of $0.00 for the 6,000 shares (transaction code A — award/grant), indicating the shares were issued as compensation rather than purchased for cash.

Key Details

• Transaction date: 2026-06-17; Filing date: 2026-06-22.
• Transaction: Award/grant of 6,000 shares; reported price $0.00; code A (award).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes/plan details: None provided in the summary; check the full Form 4 for vesting or plan references.
• Timeliness: The Form 4 was filed five days after the transaction date; this appears to be a late filing relative to the typical two-business-day reporting requirement.

Context
Awards reported at $0.00 are commonly restricted stock, RSUs, or similar compensation vehicles and do not represent an open‑market purchase. Such grants are routine compensation for directors and may vest over time; they don’t by themselves indicate immediate buying pressure or sale intent. Because McNally is a company director (not necessarily a 10% owner), this is standard insider compensation disclosure rather than a large investment signal.